Literature DB >> 9058698

Soluble E-selectin as a marker of disease activity in atopic dermatitis.

N Yamashita1, S Kaneko, O Kouro, M Furue, S Yamamoto, T Sakane.   

Abstract

BACKGROUND: Augmentation in the expression of adhesion molecules on endothelial cells can regulate leukocyte migration. These molecules are also shed into the circulation. The level of soluble adhesion molecules in the serum is known to reflect the degree of systemic inflammation, and this level can therefore be used as a marker of inflammation.
OBJECTIVE: To elucidate whether soluble adhesion molecules can be used as the marker of disease severity in atopic dermatitis, we examined the levels of soluble E-selectin, soluble intercellular adhesion molecule-1, and soluble vascular cell adhesion molecule-1 and compared these levels with the patients' symptom scores and their total serum IgE levels.
METHODS: Fifty-three patients with atopic dermatitis were studied. Soluble adhesion molecules were measured by ELISA.
RESULTS: The level of soluble E-selectin was higher in patients with atopic dermatitis than in healthy control subjects (p < 0.01). Moreover, soluble E-selectin is correlated with disease severity (p < 0.01). Soluble E-selectin also reflected the changes in symptom scores. In contrast, there were no differences in soluble intercellular adhesion molecule-1 and soluble vascular cell adhesion molecule-1 between the patients and control subjects.
CONCLUSION: Soluble E-selectin is a good marker of disease severity and of its activity in atopic dermatitis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9058698     DOI: 10.1016/s0091-6749(97)70060-5

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  5 in total

1.  Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis.

Authors:  T Kakinuma; K Nakamura; M Wakugawa; H Mitsui; Y Tada; H Saeki; H Torii; M Komine; A Asahina; K Tamaki
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

2.  Soluble intercellular adhesion molecule-1 and E-selectin in patients with asthma exacerbation.

Authors:  Mahdi Bijanzadeh; Nallur B Ramachandra; P A Mahesh; Mysore R Savitha; G S Vijayakumar; Pradeep Kumar; B S Manjunath; B S Jayaraj
Journal:  Lung       Date:  2009-08-23       Impact factor: 2.584

Review 3.  Specific immunotherapy in atopic dermatitis.

Authors:  Jungsoo Lee; Chang Ook Park; Kwang Hoon Lee
Journal:  Allergy Asthma Immunol Res       Date:  2014-11-25       Impact factor: 5.764

4.  VCAM-1 blockade delays disease onset, reduces disease severity and inflammatory cells in an atopic dermatitis model.

Authors:  Lin Chen; Shao-xia Lin; Sanober Amin; Lut Overbergh; Giacomo Maggiolino; Lawrence S Chan
Journal:  Immunol Cell Biol       Date:  2010-01-12       Impact factor: 5.126

5.  Immune imbalance in nasal polyps of Caucasian chronic rhinosinusitis patients is associated with a downregulation of E-selectin.

Authors:  Michael Könnecke; Robert Böscke; Anja Waldmann; Karl-Ludwig Bruchhage; Robert Linke; Ralph Pries; Barbara Wollenberg
Journal:  J Immunol Res       Date:  2014-06-03       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.